ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,372, issued on Nov. 18, was assigned to The Regents of the University of California (Oakland, Calif.).

"Inhibiting anti-ENPP1 antibodies" was invented by Arjun Deb (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "In certain aspects, provided herein are inhibitory anti-ENPP1 antibodies and antigen binding fragments thereof. In some aspects, provided herein are methods of treating myocardial infarction using the antibodies provided herein. In certain aspects, provided herein are nucleic acid molecules encoding the antibodies provided herein, host cells comprising such nucleic acids, and methods of making the antibodies provided herein using...